PAK4-mediated CEBPB activation upregulates CLDN4 expression to promote cell migration and invasion in breast cancer, thus, PAK4/CEBPB/CLDN4 may be a potential therapeutic target in breast cancer treatment. The gene discussed is CLDN4; the disease is breast carcinoma.